The TK2 gene helps mitochondria, the parts of cells that make energy, copy and maintain their DNA. If you carry disease causing variants in this gene, your cells may not make enough energy, especially in muscles, which can lead to weakness, delayed motor development, trouble breathing, and a mitochondrial condition called TK2 deficiency. Symptoms often start in infancy or childhood, though some people develop them later.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or direct processes throughout the body. Some carry the code for producing proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape your response to food, stress, or medications. More detail on this topic is available in the LearnHub.
Overview
TK2Gene function
What if the gene works
The TK2 gene helps mitochondria, your cells’ energy makers, build and maintain their own DNA by recycling DNA building blocks. This supports normal energy production, especially in muscle and other active tissues.
Risk
What if the gene does not work
Variants in the TK2 gene most often impair muscle energy production, causing TK2-related mitochondrial DNA depletion syndrome. People may develop muscle weakness and breathing problems, with milder later-onset forms in some and severe early childhood disease in others.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by pathogenic variants in the TK2 gene in routine clinical guidelines. The TK2 gene is an active research focus, with deoxynucleoside replacement and gene therapy being studied for TK2-related disease.
Conditions associated with TK2
Gene function
What if the gene works
If you carry the TK2 gene, it helps your cells keep the DNA inside mitochondria in working order. Mitochondria are the parts of cells that make most of your energy. This gene mainly recycles a few DNA ingredients so mitochondria can copy and maintain their own DNA.
Inside mitochondria, the TK2 gene helps recycle certain DNA ingredients into usable building blocks. This lets cells reuse materials efficiently as part of normal daily upkeep.
TK2 helps maintain a steady supply of DNA building blocks inside mitochondria. That balance supports smooth copying and routine repair of mitochondrial DNA.
One of the roles of the TK2 gene is to support the making and maintenance of mitochondrial DNA, the set of instructions used by your cells’ energy-making parts. This helps mitochondria keep working in many tissues.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TK2 gene can change the enzyme’s shape, stability, or activity, leaving cells with too few DNA building blocks to maintain mitochondrial DNA, the DNA inside the cell’s energy making parts. A key part of how TK2 gene variants affect mitochondrial DNA maintenance is how much enzyme function remains. Milder variants may leave some activity, while more severe variants can nearly block it, often linking to earlier onset and more severe mitochondrial muscle disease.
How variants are linked to conditions
Pathogenic variants in the TK2 gene cause TK2 deficiency, a rare inherited mitochondrial condition that usually affects muscle. Many people develop progressive muscle weakness, and some have trouble with breathing or swallowing; age at onset can range from infancy to adulthood. In genetic medicine, TK2 gene variants are linked most strongly to mitochondrial DNA depletion syndrome, myopathic type, and finding a disease-causing variant can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For TK2, risk is mainly tied to genetics: a child is affected when they inherit harmful TK2 changes from both parents. The age symptoms begin and how severe they are can vary, but there is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or reduce TK2-related risk.
Inheritance of TK2 variants
TK2-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the TK2 gene from each parent. When both parents carry a variant in the TK2 gene, each pregnancy has a 25% chance of resulting in an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child who inherits neither variant. In families asking how TK2 variants are inherited, mothers and fathers pass them on equally because the TK2 gene is not on a sex chromosome.
What does my TK2 result mean for my family?
For TK2-related disease, the family pattern is usually recessive, which means close relatives may also carry the changed gene. Brothers and sisters may be affected or may be healthy carriers, and parents are often carriers as well. Children of someone with a TK2-related condition will usually be carriers, and they are more likely to be affected only if the other parent also carries a TK2 change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the TK2 gene, doctors use a blood, saliva, or cheek swab sample for genetic testing. This type of genetic testing for TK2 variants reads the DNA code and looks for changes linked to TK2-related disease. Results can confirm a diagnosis, help clarify family findings, or identify a variant of uncertain significance.
When should I consider getting a genetic test?
Consider testing for the TK2 gene if there is unexplained, worsening muscle weakness, trouble breathing caused by weak breathing muscles, or a family history of TK2-related muscle disease. Testing can help confirm the cause of symptoms and show whether close relatives may also carry the same gene change.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal depends on both the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences shape how people respond to medicines. It focuses on links between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medications, genes influence how much effect a drug has or how the body handles it. This information can support more informed, personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the TK2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have concerns about symptoms, side effects, or medication changes, talk with your doctor so they can review your overall health and treatment plan.
History
The TK2 gene entered medical genetics through studies of children with an uncommon muscle and energy-related mitochondrial condition in the late 1990s and early 2000s. Researchers linked variants in the TK2 gene to mitochondrial DNA depletion syndrome, helping explain why some families had severe muscle weakness beginning in infancy or childhood. From these first observations, research expanded steadily. Scientists then described a broader range of disease patterns, including later-onset forms, which changed how doctors recognized the condition. In recent years, the gene’s history has also included work on targeted treatment approaches, especially nucleoside therapy, which brought new attention to TK2-related disease. These milestones made the TK2 gene an important part of the history of mitochondrial medicine.